Basic Care Migraine Relief

Description

Acetaminophen/Aspirin (NSAID)/Caffeine tablets are formulated as gelatin-coated tablets. Each container includes 80 gelatin-coated tablets, designed for oral administration. The combination of acetaminophen, aspirin, and caffeine provides a multi-faceted approach to pain relief and anti-inflammatory action. The gelatin coating facilitates ease of swallowing and enhances the stability of the active ingredients.

Uses and Indications

This drug is indicated for the treatment of migraine.

There are no teratogenic effects associated with this medication, and no nonteratogenic effects have been reported.

Dosage and Administration

Adults should take 2 geltabs with a full glass of water. It is imperative that no more than 2 geltabs are taken within a 24-hour period unless otherwise directed by a healthcare professional. For individuals under 18 years of age, it is recommended to consult a doctor prior to use. Adherence to these guidelines is essential to ensure safe and effective use of the medication.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to acetaminophen, aspirin, or any other pain reliever/fever reducer. Additionally, this product should not be used concurrently with any other medication containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Warnings and Precautions

Children and teenagers who are experiencing or recovering from chickenpox or flu-like symptoms should not use this product due to the risk of Reye’s syndrome. If any changes in behavior accompanied by nausea and vomiting occur while using this product, it is imperative to consult a healthcare professional, as these symptoms may indicate the onset of this rare but serious condition.

Allergy Alerts This product contains acetaminophen, which may lead to severe skin reactions. Symptoms of such reactions can include skin reddening, blisters, and rash. If any of these symptoms occur, the use of the product should be discontinued immediately, and medical assistance should be sought.

Additionally, aspirin, another component of this product, may cause severe allergic reactions characterized by hives, facial swelling, asthma (wheezing), and shock. Immediate medical attention is required if any of these symptoms manifest.

Liver Warning The presence of acetaminophen in this product necessitates caution, as severe liver damage may occur under certain conditions. This includes exceeding the maximum daily dosage of 2 geltabs within a 24-hour period, concurrent use with other medications containing acetaminophen, or consumption of three or more alcoholic drinks daily while using this product.

Stomach Bleeding Warning As this product contains a nonsteroidal anti-inflammatory drug (NSAID), there is a risk of severe stomach bleeding. The likelihood of this adverse effect increases in individuals who are 60 years of age or older, have a history of stomach ulcers or bleeding problems, are taking anticoagulants or steroid medications, are using other NSAIDs (including aspirin, ibuprofen, or naproxen), consume three or more alcoholic drinks daily, or exceed the recommended duration or dosage of the product.

Medication Overuse Headache Warning Prolonged use of this product, specifically for 10 or more days per month, may exacerbate headache conditions.

Caffeine Warning The recommended dosage of this product contains approximately the same amount of caffeine as a standard cup of coffee. It is advisable to limit the intake of other caffeine-containing medications, foods, or beverages during treatment, as excessive caffeine consumption may lead to severe nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat.

Emergency Medical Help In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222.

Discontinuation of Use Healthcare professionals should advise patients to stop using this product and seek medical advice if any of the following occur: an allergic reaction, signs of stomach bleeding (such as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain), if a migraine is not alleviated or worsens after the first dose, if new or unexpected symptoms arise, or if there is ringing in the ears or loss of hearing.

Side Effects

Patients using this product may experience a range of adverse reactions, some of which may be serious.

Warnings Reye’s syndrome is a rare but serious illness that can occur in children and teenagers who have or are recovering from chickenpox or flu-like symptoms. These individuals should not use this product. If patients exhibit changes in behavior accompanied by nausea and vomiting while using this product, they should consult a doctor immediately, as these symptoms may indicate the onset of Reye’s syndrome.

Severe skin reactions have been reported in patients using acetaminophen, which may manifest as skin reddening, blisters, or rash. If any of these symptoms occur, patients should discontinue use and seek medical assistance promptly. Additionally, aspirin may provoke severe allergic reactions, including hives, facial swelling, asthma (wheezing), and shock.

Patients should be aware of the potential for severe liver damage associated with acetaminophen, particularly if they exceed the maximum daily dosage of 2 geltabs within 24 hours, use other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using this product.

The presence of an NSAID in this product raises the risk of severe stomach bleeding, especially in patients aged 60 or older, those with a history of stomach ulcers or bleeding problems, and individuals taking anticoagulants or steroids. The risk is further heightened with concurrent use of other NSAIDs or excessive alcohol consumption.

Patients may also experience medication overuse headaches if this product is used for 10 or more days per month. Furthermore, the recommended dose contains caffeine equivalent to a cup of coffee, and patients should limit the intake of other caffeine-containing products to avoid severe nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat.

Stop Use and Ask a Doctor If Patients should seek medical attention if they experience any signs of an allergic reaction or symptoms indicative of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. Additionally, if a migraine is not relieved or worsens after the first dose, or if new or unexpected symptoms arise, patients should consult a healthcare professional. Ringing in the ears or loss of hearing should also prompt immediate medical advice.

Additional Adverse Reactions or Important Notes Before using this product, patients should consult a doctor if they have never had migraines diagnosed by a health professional, experience headaches that differ from their usual migraines, or have the worst headache of their life. Other concerning symptoms include fever and stiff neck, headaches following head injury, exertion, coughing, or bending, and the onset of headaches after age 50. Patients with daily headaches, severe migraines requiring bed rest, liver disease, or a history of stomach problems should also seek medical advice prior to use. Those with high blood pressure, heart disease, liver cirrhosis, kidney disease, or who are taking diuretics or have asthma should exercise caution. Lastly, patients who have experienced vomiting with migraine headaches should consult a healthcare provider before using this product.

Drug Interactions

Concurrent use of this product with other medications containing acetaminophen is contraindicated due to the potential for hepatotoxicity. Additionally, the use of this product alongside other prescription or nonprescription nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen, or naproxen, is also contraindicated, as it may increase the risk of gastrointestinal bleeding and other adverse effects.

Patients are advised to consult a healthcare professional prior to using this product if they are concurrently taking anticoagulants or steroid medications, as these combinations may necessitate careful monitoring or dosage adjustments to mitigate the risk of bleeding or other complications.

Furthermore, it is recommended to limit the intake of caffeine-containing medications, foods, or beverages while using this product, as excessive caffeine may exacerbate side effects or lead to increased stimulation.

No specific laboratory test interactions have been identified in the available data.

Packaging & NDC

Below are the non-prescription pack sizes of Basic Care Migraine Relief (acetaminophen, aspirin, caffeine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Children and teenagers who have or are recovering from chickenpox or flu-like symptoms should not use this product due to the risk of Reye’s syndrome, a rare but serious illness. If any changes in behavior accompanied by nausea and vomiting occur while using this product, it is essential to consult a doctor, as these may be early signs of Reye’s syndrome.

This product should be kept out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or a Poison Control Center should be contacted, as prompt medical attention is critical for both adults and children, even if no signs or symptoms are apparent.

For individuals under 18 years of age, it is advised to consult a doctor before use.

Geriatric Use

Elderly patients, specifically those aged 60 years and older, should consult a healthcare provider prior to using this medication. This precaution is essential to ensure the safe and effective use of the treatment in this population, as age-related physiological changes may influence drug metabolism and response. Careful consideration and monitoring are advised when prescribing to geriatric patients to mitigate potential risks and optimize therapeutic outcomes.

Pregnancy

Pregnant patients and women who are breastfeeding should consult a healthcare professional before using this medication. The use of aspirin during pregnancy, particularly at 20 weeks gestation or later, is associated with potential risks. Specifically, aspirin may lead to adverse effects in the unborn child or complications during delivery. Therefore, it is crucial that pregnant patients only use aspirin under the guidance of a qualified healthcare provider.

Lactation

Lactating mothers are advised to consult a health professional before using this medication. It is particularly important to avoid the use of aspirin at 20 weeks of pregnancy or later unless specifically directed by a doctor, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment may require careful consideration regarding dosing adjustments and monitoring. In individuals with reduced kidney function, particularly those with high blood pressure, heart disease, liver cirrhosis, or kidney disease, it is essential to assess renal function prior to initiating treatment. Regular monitoring of renal parameters is recommended to ensure safety and efficacy. Adjustments to the dosing regimen may be necessary based on the degree of renal impairment to avoid potential adverse effects and to optimize therapeutic outcomes.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical that patients do not exceed the maximum daily dosage of 2 geltabs within a 24-hour period. Additionally, patients must avoid concurrent use with other medications containing acetaminophen and limit alcohol consumption to fewer than 3 drinks per day while using this product.

Before initiating treatment, patients with liver disease or those with conditions such as high blood pressure, heart disease, liver cirrhosis, or kidney disease should consult a healthcare professional. Monitoring of liver function may be warranted in these patients to ensure safety and efficacy during treatment.

Overdosage

In cases of overdosage, significant health risks are associated with the consumption of this product.

Risk of Severe Liver Damage Healthcare professionals should be aware that severe liver damage may occur if a patient ingests more than 2 geltabs within a 24-hour period, which is the established maximum daily dosage. Additionally, the concomitant use of this product with other medications containing acetaminophen can also lead to severe liver damage.

Furthermore, patients who consume three or more alcoholic beverages daily while using this product are at an increased risk for severe liver damage.

Recommended Actions In the event of suspected overdosage, it is imperative to assess the patient's liver function and consider immediate medical intervention. Monitoring of liver enzymes and supportive care may be necessary, depending on the severity of the symptoms presented. Prompt recognition and management of overdosage are crucial to mitigate potential complications.

Nonclinical Toxicology

It is especially important not to use aspirin at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects or additional nonclinical toxicology details are available in the provided data. Furthermore, there are no specific findings related to animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions associated with the use of this product. Severe skin reactions, including skin reddening, blisters, rash, hives, and facial swelling, have been reported in association with acetaminophen. Additionally, severe allergic reactions linked to aspirin may manifest as asthma (wheezing) and shock.

The use of this product, which contains a nonsteroidal anti-inflammatory drug (NSAID), may lead to stomach bleeding. Medication overuse headache has also been noted, particularly in individuals using the product for 10 or more days per month. New or unexpected symptoms may arise during treatment, including tinnitus (ringing in the ears) or hearing loss.

Signs indicative of stomach bleeding, such as feeling faint, vomiting blood, having bloody or black stools, and experiencing persistent stomach pain, have been reported. If a migraine is not alleviated or worsens following the initial dose, it is advised that medical attention be sought. Furthermore, an allergic reaction may occur, necessitating immediate medical assistance.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose. Quick medical attention is essential for both adults and children, even if no signs or symptoms are apparent.

It is important to inform patients that they should not use this medication if they have a history of allergic reactions to acetaminophen, aspirin, or any other pain reliever or fever reducer. Additionally, patients must be cautioned against using this medication in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they should be encouraged to consult a doctor or pharmacist.

Patients should be instructed to discontinue use and consult a doctor if they experience any signs of an allergic reaction or if they notice any of the following symptoms indicative of stomach bleeding: feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve. They should also seek medical advice if their migraine is not relieved or worsens after the first dose, if new or unexpected symptoms arise, or if they experience ringing in the ears or loss of hearing.

Before initiating treatment, patients should be advised to consult a doctor if they have never had migraines diagnosed by a healthcare professional, if they have a headache that differs from their usual migraines, or if they are experiencing the worst headache of their life. Patients should also seek medical advice if they have a fever accompanied by a stiff neck, if headaches begin after or are caused by head injury, exertion, coughing, or bending, or if they experienced their first headache after the age of 50. Furthermore, patients with daily headaches or migraines severe enough to require bed rest should consult a doctor prior to use.

Patients with liver disease, a history of stomach problems such as heartburn, high blood pressure, heart disease, liver cirrhosis, or kidney disease should also be advised to seek medical consultation before using this medication. Additionally, patients taking diuretics, those with asthma, or those who have experienced serious side effects from pain relievers or fever reducers should consult a doctor before use. Patients experiencing vomiting with a migraine headache should also seek medical advice.

Finally, patients should be encouraged to consult a doctor or pharmacist before using this medication if they are taking any prescription drugs for diabetes, gout, arthritis, or are under a doctor’s care for any serious condition. They should also inquire with a doctor or pharmacist if they are taking any other medications or products that contain aspirin, acetaminophen, or any other pain reliever or fever reducer.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at a controlled temperature range of 20° to 25°C (68° to 77°F) to maintain its efficacy and safety.

After each use, the cap must be closed tightly to prevent contamination and ensure the integrity of the product. Users are advised to read all product information thoroughly before use and to retain the packaging for future reference, as it contains important information regarding the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Basic Care Migraine Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)